Fifth Third Bancorp Mannkind Corp Transaction History
Fifth Third Bancorp
- $28.3 Billion
- Q2 2025
A detailed history of Fifth Third Bancorp transactions in Mannkind Corp stock. As of the latest transaction made, Fifth Third Bancorp holds 500 shares of MNKD stock, worth $2,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$2,880
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MNKD
# of Institutions
250Shares Held
161MCall Options Held
1.24MPut Options Held
183K-
Black Rock Inc. New York, NY22.6MShares$130 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$105 Million0.0% of portfolio
-
State Street Corp Boston, MA10.7MShares$61.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.62MShares$43.9 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY7.01MShares$40.4 Million4.77% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.48B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...